[CLSTR]
API
< Back to situations

This situation has concluded

It was preserved as a record on November 6; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 6 sources · 1 days · First seen · Last updated

EU worker health and safety regulation updates

Overview

The European Parliament has moved to strengthen worker protections through two primary legislative focuses: chemical safety and mental health.

Regarding chemical safety, the Parliament approved a sixth revision of the Carcinogens, Mutagens and Reprotoxic substances Directive (CMRD). This update introduces new exposure limit values for hazardous substances such as cobalt, polycyclic aromatic hydrocarbons, and 1,4-dioxane. The directive also mandates enhanced training and protective equipment for high-risk sectors, including emergency services and chemical production, to combat occupational cancer.

In a separate non-binding initiative, MEPs voted to urge the European Commission to establish rules addressing psychosocial risks. The proposed measures aim to reduce workplace stress, burnout, and bullying, while emphasizing the importance of regular risk assessments regarding workload and algorithmic management. The initiative also reiterates the workers’ right to disconnect.

Entities

European Parliament · Slovak Ministry of Health · Slovak National Council · European Commission

Timeline

  1. [POLITICS] 3 sources
    European Parliament advances worker protections for mental health and chemical safety

    The European Parliament has moved to strengthen worker protections, targeting both mental health risks like burnout and physical hazards from exposure to dangerous carcinogens.

  2. [HEALTH] 3 sources
    EU and Slovakia implement new health and safety regulations

    The European Parliament updated chemical safety standards for workers, while Slovakia passed reforms to control new narcotic substances and improve patient access to innovative medicines.

Sources

aktuality.sk · cde.news · eubusiness.com · europske.noviny.sk · via.tt.se · www1.pluska.sk